Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung.

The long-term persistance of P. aeruginosa in the cystic fibrosis (CF) lung is characterized by the selection of a variety of genotypes and phenotypes that typically descend from one infecting P. aeruginosa clone, a process known as adaptive radiation. This adaptation process of P. aeruginosa includes complex physiological changes that likely confer a selective advantage to better thrive in the diverse niches and microenvironments of the inflamed and hostile CF airways. The occurrence of P. aeruginosa variants is fixed by mutation and selection. Common loss-of-function mutations in genes such as lasR, mucA and mexT lead to a general adaptation pattern and P. aeruginosa variants with increased antimicrobial resistance, alginate overproduction, reduced acute virulence, and improved metabolic fitness. Strikingly, several virulence-associated traits and immunostimulatory components of P. aeruginosa are turned off. In contrast, other cellular factors are positively selected such as the outer membrane protein OprF, the blue copper protein azurin, the cytochrome c peroxidase c551, and the enzymes of the arginine deiminase pathway ArcA-ArcD. These metabolic components probably are required for the optimal anaerobic or microaerobic growth and viability of P. aeruginosa within CF airways. Besides these common adaptations found by the comparison of P. aeruginosa isolates from different CF patients, the overall diversity of isogenic isolates from one CF patient is extended by variable changes in the expression of regulatory-, transport-, metabolic-, and virulence-associated genes. A better understanding of the microevolution of P. aeruginosa towards niche specialists according the selection pressure in the CF lung is a prerequisite to develop new strategies for the detection of P. aeruginosa variants, the antipseudomonal treatment, the prediction of the infectious disease state, and the development of efficient vaccines.

[1]  Y Comeau,et al.  Initiation of Biofilm Formation byPseudomonas aeruginosa 57RP Correlates with Emergence of Hyperpiliated and Highly Adherent Phenotypic Variants Deficient in Swimming, Swarming, and Twitching Motilities , 2001, Journal of bacteriology.

[2]  Anjana Ray,et al.  Increased sputum amino acid concentrations and auxotrophy ofPseudomonas aeruginosa in severe cystic fibrosis lung disease , 2000, Thorax.

[3]  Pradeep K. Singh,et al.  Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Axel Imhof,et al.  Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. , 2009, The Journal of infectious diseases.

[5]  J. Heesemann,et al.  Expression of Pseudomonas aeruginosa exoS is controlled by quorum sensing and RpoS. , 2004, Microbiology.

[6]  Richard C Boucher,et al.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.

[7]  M. Son,et al.  In Vivo Evidence of Pseudomonas aeruginosa Nutrient Acquisition and Pathogenesis in the Lungs of Cystic Fibrosis Patients , 2007, Infection and Immunity.

[8]  George M. Hilliard,et al.  Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. , 2002, Developmental cell.

[9]  R. Hancock,et al.  Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains , 1983, Infection and immunity.

[10]  David A. D'Argenio,et al.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. P. Speert,et al.  Genetic Adaptation of Pseudomonas aeruginosa to the Airways of Cystic Fibrosis Patients Is Catalyzed by Hypermutation , 2008, Journal of bacteriology.

[12]  David A. D'Argenio,et al.  Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients , 2007, Molecular microbiology.

[13]  The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections. , 2009, FEMS microbiology letters.

[14]  V. Deretic,et al.  Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection , 1997, Infection and immunity.

[15]  G. Pier,et al.  Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. , 2005, The Journal of infectious diseases.

[16]  T. Pitt,et al.  The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. , 1996, Journal of medical microbiology.

[17]  David A. D'Argenio,et al.  Autolysis and Autoaggregation in Pseudomonas aeruginosa Colony Morphology Mutants , 2002, Journal of bacteriology.

[18]  S. Häussler Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa. , 2004, Environmental microbiology.

[19]  E. Mahenthiralingam,et al.  Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis , 1994, Infection and immunity.

[20]  A. Oliver,et al.  High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. , 2000, Science.

[21]  S. Lory,et al.  Multiple activities of c-di-GMP in Pseudomonas aeruginosa. , 2009, Nucleic acids symposium series.

[22]  M. Whiteley,et al.  Nutritional Cues Control Pseudomonas aeruginosa Multicellular Behavior in Cystic Fibrosis Sputum , 2007, Journal of bacteriology.

[23]  B. Tümmler,et al.  Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  S. Miller,et al.  Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. , 1999, Science.

[25]  Matthew R. Parsek,et al.  Pseudomonas aeruginosa Rugose Small-Colony Variants Have Adaptations That Likely Promote Persistence in the Cystic Fibrosis Lung , 2009, Journal of bacteriology.

[26]  Samuel I. Miller,et al.  Human Toll-like receptor 4 recognizes host-specific LPS modifications , 2002, Nature Immunology.

[27]  C. Di Serio,et al.  Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. , 2009, American journal of respiratory and critical care medicine.

[28]  S. Molin,et al.  Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. , 1999, Microbiology.

[29]  R. Locy,et al.  Isocitrate Lyase Supplies Precursors for Hydrogen Cyanide Production in a Cystic Fibrosis Isolate of Pseudomonas aeruginosa , 2009, Journal of bacteriology.

[30]  Joseph O Matu,et al.  Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. , 2009, Trends in microbiology.

[31]  N. Høiby,et al.  Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. , 2008, Microbiology.

[32]  J. Klockgether,et al.  An intragenic deletion in pilQ leads to nonpiliation of a Pseudomonas aeruginosa strain isolated from cystic fibrosis lung. , 2007, FEMS microbiology letters.

[33]  S. Suh,et al.  Adaptations of Pseudomonas aeruginosa to the Cystic Fibrosis Lung Environment Can Include Deregulation of zwf, Encoding Glucose-6-Phosphate Dehydrogenase , 2005, Journal of bacteriology.

[34]  U. Römling,et al.  Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs , 2002, Molecular microbiology.

[35]  V. Deretic,et al.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. , 1996, Microbiological reviews.

[36]  J. Emerson,et al.  Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. , 2001, The Journal of infectious diseases.

[37]  J. Heesemann,et al.  Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis. , 2007, The Journal of infectious diseases.